A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapy

BACKGROUND: Brain metastases are a common complication of advanced non-small cell lung cancer (NSCLC). Patients with brain metastases were excluded from the registration trials of bevacizumab that showed a survival benefit with the use of angiogenesis inhibition. METHODS: In this study, we pooled da...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Gubens, Matthew A., Chuang, Jody C., Akerley, Wallace, Langer, Corey J., Clément-Duchêne, Christelle, San Pedro-Salcedo, Melanie, Colevas, A. Dimitrios, Dragnev, Konstantin, Socinski, Mark A., Wakelee, Heather A.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5863135/
https://ncbi.nlm.nih.gov/pubmed/29600052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.12.30
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados